Blog - QualityStocks

MondayMar 09, 2026 12:00 pm

Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy

LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to improve outcomes for cancer patients Specifically, Liora’s Linac for Image Guided Hadron Therapy (“LiGHT”) System and LIXTE’s LB-100 work together to fight cancer As a result, the companies are building a new cancer care ecosystem that hopes to boost the effectiveness of treatments, while also help them be more accessible for a wider range of patients Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy. Specifically,…

MondayMar 09, 2026 11:15 am

Renewal Fuels Inc. (RNWF) Expands Leadership and Targets 2026 Milestone for Texatron(TM) Fusion Platform

Appointment of fusion researcher Fabrice David adds scientific oversight as commercialization plans advance. Travis Yakimishyn joins as Chief Electrical & Power Systems Officer to lead utility-scale integration. The company is transitioning to American Fusion Inc. following its merger with Kepler Fusion Technologies, with filing and audits nearing completion as the company prepares for SEC reporting status. Management reiterates goal of deploying a 100-megawatt operational unit by year-end 2026, with Kepler‘s plan to sell electricity on a per-kilowatt basis to utilities and industrial customers. Renewal Fuels (OTC: RNWF) (d/b/a American Fusion), an advanced energy platform company focused on the development and…

MondayMar 09, 2026 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Secures Key European Milestone for Dusquetide Development

“The EMA's positive opinion signifies an important step for Soligenix as we continue to advance the program,” says company CEO. The designation provides incentives that may include protocol assistance, reduced regulatory fees and up to 10 years of market exclusivity following approval. Dusquetide is classified as an innate defense regulator, a type of compound designed to modulate the body’s innate immune system rather than suppress it outright. For patients living with rare inflammatory diseases, regulatory milestones can mark the difference between stalled research and meaningful therapeutic progress. A positive opinion from the European Medicines Agency (EMA) not only validates a…

MondayMar 09, 2026 9:55 am

QualityStocksNewsBreaks – Octane Announces Neuro Tech Forum 2026 to Be Held March 26-27 in Newport Beach

Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California, bringing together industry leaders, clinicians, investors and entrepreneurs to advance innovation in neurotechnology. The event, part of Octane’s Innovation Event Series, will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers addressing emerging neurotech technologies, digital health innovation, brain-computer interfaces and the evolving investment landscape. The forum will include innovation panels, investor-focused sessions, company presentations and networking opportunities designed to foster…

MondayMar 09, 2026 9:45 am

HeartBeam Inc. (NASDAQ: BEAT) Moves Forward Focused on Advancing Portable, High-Fidelity Cardiac Monitoring

The company’s core innovation, the HeartBeam System, is positioned as the first cable-free, high-fidelity ECG system capable of capturing the heart’s electrical signals from three distinct directions. HeartBeam’s strategy is built around addressing a long-standing gap in cardiac care. Looking forward, HeartBeam is focused on advancing both its hardware and software platforms. HeartBeam (NASDAQ: BEAT) stands at a pivotal point in its development as a medical technology company focused on transforming how cardiac arrhythmias are detected, evaluated and monitored. Headquartered in Santa Clara, California, HeartBeam is building a platform designed starting with its FDA-cleared synthesized 12-lead ECG system to bring…

MondayMar 09, 2026 9:40 am

QualityStocksNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Announces 1-for-3 Reverse Share Split to Maintain Nasdaq Listing Compliance

Wearable Devices (NASDAQ: WLDS), a technology growth company specializing in artificial intelligence-powered touchless sensing wearables, announced it will implement a one-for-three reverse split of its ordinary shares and tradable warrants, effective when trading begins on a split-adjusted basis on March 11, 2026. The action is intended to increase the company’s per-share trading price to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. Following the reverse split, the number of issued and outstanding ordinary shares will be reduced from 10,593,227 to approximately 3,531,076, while publicly held warrants will decrease from 98,589 to about 32,863, with…

MondayMar 09, 2026 9:22 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing advanced cardiac insights, announced that its management team will attend several investor and industry conferences in March 2026. CEO Robert Eno and CFO Timothy Cruickshank will participate in the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, including a webcast presentation on March 16, while also meeting with institutional and retail investors. The executives will also attend the 38th Annual ROTH Conference in Dana Point, California, on March 23-24, where Eno will join a panel on technologies advancing healthy aging. In addition, Eno, Founder and President Dr. Branislav Vajdic and…

MondayMar 09, 2026 9:20 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Establishes Operational Environment for Ukraine Field Testing of Overwatch Platform

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced that it has established the operational environment for its Overwatch GPS-denied navigation and targeting platform for the Ukraine market and expects to deliver the system this week as part of operational field testing first announced in February 2026. The testing will evaluate the platform’s navigation and target acquisition capabilities under persistent GPS jamming and degraded signal conditions, providing a key validation milestone for defense and security applications in contested environments. In conjunction with the deployment,…

MondayMar 09, 2026 9:10 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Opens Palm Beach Clinic for Depression and PTSD Treatment

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its subsidiary HOPE Therapeutics has opened a new clinic in Palm Beach, Florida, focused on treating depression and post-traumatic stress disorder through an interventional psychiatry approach that includes ketamine and other neuroplastic drugs, transcranial magnetic stimulation (TMS), hyperbaric oxygen therapy and physician-led psychotherapy. The facility expands HOPE’s growing network of clinics and builds on a nationwide partnership with neurocare AG to bring non-invasive neuroplastic therapies to patients. Peer-reviewed publications cited by the company report an 87% clinical response rate in treatment-resistant depression using short-term treatment protocols, while pilot programs incorporating hyperbaric oxygen therapy have…

MondayMar 09, 2026 9:00 am

QualityStocksNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Files Updated Mineral Resource Estimate for Kyrgyzstan Gold Projects

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced the filing of an updated Mineral Resource Estimate for the Tulkubash and Kyzyltash Chaarat Gold Projects in the Republic of Kyrgyzstan through a National Instrument 43-101 technical report titled “NI 43-101 Technical Report and Updated Mineral Resource Estimate for the Tulkubash And Kyzyltash Chaarat Gold Project Republic Of Kyrgyzstan,” effective Oct. 15, 2025. The report was prepared in accordance with Canadian Securities Administrators’ National Instrument 43-101 – Standards of Disclosure for Mineral Projects and is available on…

Site Search

Company Search